DALLAS, Dec. 14, 2011 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces a stock report featuring Alexza Pharmaceuticals Inc. (Nasdaq:ALXA). The report details the company's most recent developments and news, outlines its financial position and market performance, and includes an easy-to-read stock chart.
MicroStockProfit.com is the premier destination for investment information, making your trading decisions easier than ever. Get the rundown on how ALXA stacks up against its competitors and check-out the stock's technical data by viewing the free, in-depth report for ALXA at: http://www.microstockprofit.com/lp/ALXA
This newsletter has been helping traders make great investment decisions on ALXA; click here for a 15% discount offer.
In the report, the analyst notes:
"Alexza Pharmaceuticals Inc. (ALXA) climbed as high as $1.00, or 59%, yesterday following news that the Psychopharmacologic Drugs Advisory Committee (PDAC) of the FDA voted to recommend that ADASUVE (Staccato loxapine) be approved for use as a single dose in 24 hours ..."
"ALXA reported revenues of $1.3 million for the three months ended September 30, 2011, compared to $0.7 million in the three months ended September 30, 2010. Revenues for the nine months ended September 30, 2011, amounted to $3.8 million, compared to $0.7 million for the same period last year."
To read the entire report visit: www.microstockprofit.com/lp/ALXA
See what investors are saying about ALXA at http://www.stockhideout.com
Get breaking news on ALXA at http://thestockmarketwatch.com/
MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. Please visit http://www.microstockprofit.com for more information.
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor; nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.